Po‐Tsang Lee

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Salmonids Have an Extraordinary Complex Type I IFN System: Characterization of the IFN Locus in Rainbow Trout <i>Oncorhynchus mykiss</i> Reveals Two Novel IFN Subgroups

Jun Zou, Bartolomeo Gorgoglione, N.G.H. Taylor et al. · The Journal of Immunology · 2014 · 112 citations

Renal Protection for Coronary Angiography in Advanced Renal Failure Patients by Prophylactic Hemodialysis

Po‐Tsang Lee, Kang-Ju Chou, Chun-Peng Liu et al. · Journal of the American College of Cardiology · 2007 · 111 citations

Hemodialysis, Urology, Prophylactic Hemodialysis +14

The Clinical Impact of Bacteremia in Complicated Acute Pyelonephritis

Chih‐Yang Hsu, Hua-Chang Fang, Kang-Ju Chou et al. · The American Journal of the Medical Sciences · 2006 · 92 citations

Glomerulonephritis, Urology, Antibiotics +6